wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q54976582-03A46E9E-EBED-4FE5-B640-D5259D92A1D7
Q54976582-03A46E9E-EBED-4FE5-B640-D5259D92A1D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54976582-03A46E9E-EBED-4FE5-B640-D5259D92A1D7
A Computational Approach for Prioritizing Selection of Therapies Targeting Drug Resistant Variation in Anaplastic Lymphoma Kinase.
P2860
Q54976582-03A46E9E-EBED-4FE5-B640-D5259D92A1D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54976582-03A46E9E-EBED-4FE5-B640-D5259D92A1D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fcf3cec8091f1079b4dc9b6e2275def90e58bf48
P2860
Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor